Dopamine signaling leads to loss of Polycomb repression and aberrant gene activation in experimental parkinsonism.

Södersten, Erik

Dopamine signaling leads to loss of Polycomb repression and aberrant gene activation in experimental parkinsonism. [electronic resource] - PLoS genetics Sep 2014 - e1004574 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1553-7404

10.1371/journal.pgen.1004574 doi


Animals
Disease Models, Animal
Dopamine--metabolism
Dopamine and cAMP-Regulated Phosphoprotein 32--metabolism
Female
Gene Expression Regulation--drug effects
Genetic Loci
Histones--metabolism
Levodopa--pharmacology
Mice
Mice, Knockout
Parkinsonian Disorders--genetics
Phosphorylation--drug effects
Polycomb-Group Proteins--genetics
Protein Binding
RNA, Messenger--genetics
Ribosomal Protein S6 Kinases, 90-kDa--metabolism
Signal Transduction
Transcriptional Activation